157 related articles for article (PubMed ID: 26515659)
1. Long-term effects of Alzheimer's disease treatment.
Wimo A
Lancet Neurol; 2015 Dec; 14(12):1145-6. PubMed ID: 26515659
[No Abstract] [Full Text] [Related]
2. Alzheimer disease. Donepezil and nursing home placement--benefits and costs.
Jelic V; Winblad B
Nat Rev Neurol; 2016 Jan; 12(1):11-3. PubMed ID: 26714658
[TBL] [Abstract][Full Text] [Related]
3. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
Howard R; McShane R; Lindesay J; Ritchie C; Baldwin A; Barber R; Burns A; Dening T; Findlay D; Holmes C; Jones R; Jones R; McKeith I; Macharouthu A; O'Brien J; Sheehan B; Juszczak E; Katona C; Hills R; Knapp M; Ballard C; Brown RG; Banerjee S; Adams J; Johnson T; Bentham P; Phillips PP
Lancet Neurol; 2015 Dec; 14(12):1171-81. PubMed ID: 26515660
[TBL] [Abstract][Full Text] [Related]
4. First drug for moderate-to-severe Alzheimer's.
FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
[No Abstract] [Full Text] [Related]
5. Memantine for patients with Alzheimer disease.
Finucane TE
JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
[No Abstract] [Full Text] [Related]
6. [Advances in Alzheimer's disease treatment].
Nourhashémi F
Rev Med Interne; 2006 Aug; 27(8):585-7. PubMed ID: 16782240
[No Abstract] [Full Text] [Related]
7. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
[No Abstract] [Full Text] [Related]
8. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
Papageorgiou SG; Kontaxis T; Antelli A; Kalfakis N
J Clin Psychopharmacol; 2007 Aug; 27(4):407-8. PubMed ID: 17632233
[No Abstract] [Full Text] [Related]
9. Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
Torjesen I
BMJ; 2015 Oct; 351():h5739. PubMed ID: 26506953
[No Abstract] [Full Text] [Related]
10. UK government guidance on Alzheimer's drugs postponed.
O'Neill MF
Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
[No Abstract] [Full Text] [Related]
11. Another advertisement for donepezil.
Finucane TE
J Am Geriatr Soc; 2004 May; 52(5):843; author reply 845-6. PubMed ID: 15086674
[No Abstract] [Full Text] [Related]
12. Improving functioning in patients with Alzheimer's.
J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):11-2. PubMed ID: 9604834
[No Abstract] [Full Text] [Related]
13. [Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil].
Creţu O; Szalontay AS; Chiriţă R; Chiriţă V
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):641-5. PubMed ID: 20201245
[TBL] [Abstract][Full Text] [Related]
14. New drug treatment for Alzheimer's disease. Effects of drugs can be variable.
Levy R
BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9841008
[No Abstract] [Full Text] [Related]
15. Refining treatment guidelines in Alzheimer's disease.
Doody RS
Geriatrics; 2005 Jun; Suppl():14-20. PubMed ID: 16025771
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
17. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
[TBL] [Abstract][Full Text] [Related]
18. Memantine-related psychotic symptoms in a patient with bipolar disorder.
Canan F; Ataoglu A
J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
[No Abstract] [Full Text] [Related]
19. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
Baxter T; Black D; Prempeh H
BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
[No Abstract] [Full Text] [Related]
20. Donepezil delay to nursing home placement study is flawed.
Karlawish JH
J Am Geriatr Soc; 2004 May; 52(5):845; author reply 845-6. PubMed ID: 15086676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
